NCT07043738View on ClinicalTrials.gov

Imaging- vs. Scalp-Targeted Accelerated TMS for Depression: The Number Needed to Scan Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2030

Study Completion Date

September 1, 2031

Conditions
Major Depressive Disorder (MDD)
Interventions
PROCEDURE

Transcranial Magnetic Stimulation

Transcranial magnetic stimulation (TMS) is a focal, non-invasive form of brain stimulation that has FDA clearance for depression. In this study, a form of TMS called accelerated intermittent theta burst stimulation (aiTBS) will be administered under the supervision of a physician with TMS expertise.

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Brigham and Women's Hospital

OTHER